ursodeoxycholic acid has been researched along with Hematochezia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; Floreani, A; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; Verhelst, X | 1 |
| Silveira, M; To, U | 1 |
| Bergquist, A; Bottai, M; Höijer, J; Söderberg-Löfdal, K; Stokkeland, K | 1 |
| Jaikishen, JP; Lamarche, MB; Sokol, L; Stueben, ET | 1 |
| Dickson, ER; Kim, WR | 1 |
| Angulo, P; Lindor, KD; Silveira, MG; Talwalkar, JA | 1 |
| Hasegawa, M; Kuwano, H; Matsui, A; Morikawa, A; Onigata, K; Suehiro, T; Sumazaki, R; Suzuki, M; Suzuki, T; Takahashi, A; Toki, F; Tomomasa, T | 1 |
2 review(s) available for ursodeoxycholic acid and Hematochezia
| Article | Year |
|---|---|
Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis.
Topics: Ascites; Cholagogues and Choleretics; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glucocorticoids; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Mortality; Ursodeoxycholic Acid | 2018 |
Predictive models of natural history in primary biliary cirrhosis.
Topics: Disease Progression; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Biliary; Models, Theoretical; Survival Rate; Ursodeoxycholic Acid | 1998 |
5 other study(ies) available for ursodeoxycholic acid and Hematochezia
| Article | Year |
|---|---|
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
Topics: Adult; Aged; Ascites; Aspartate Aminotransferases; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Esophageal and Gastric Varices; Europe; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Incidence; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; North America; Platelet Count; Population Growth; Prognosis; Proportional Hazards Models; Risk Factors; Ursodeoxycholic Acid | 2018 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Mesalamine; Middle Aged; Mortality; Proportional Hazards Models; Protective Factors; Registries; Sweden; Ursodeoxycholic Acid | 2019 |
Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Esophageal and Gastric Varices; Factor VIII; Female; Gastrointestinal Hemorrhage; Humans; Hypersplenism; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Partial Thromboplastin Time; Platelet Count; Portasystemic Shunt, Surgical; Thrombocytopenia; Turner Syndrome; Ursodeoxycholic Acid; von Willebrand Diseases; von Willebrand Factor | 2002 |
Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.
Topics: Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Syndrome; Ursodeoxycholic Acid | 2007 |
Gradual improvement of liver function after administration of ursodeoxycholic acid in an infant with a novel ABCB11 gene mutation with phenotypic continuum between BRIC2 and PFIC2.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Follow-Up Studies; Gastrointestinal Hemorrhage; Growth Hormone; Humans; Infant; Liver; Male; Mutation, Missense; Phenotype; Polymorphism, Restriction Fragment Length; Ursodeoxycholic Acid; Vitamin K | 2007 |